Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: We sought to obtain preliminary data regarding the efficacy of omega-3 fatty acids for major depressive disorder associated with the menopausal transition. Secondary outcomes were assessed for vasomotor symptoms (or hot flashes). METHODS: After a single-blind placebo lead-in, participants received 8 weeks of treatment with open-label omega-3 fatty acid capsules (eicosapentaenoic acid and docosahexaenoic acid, 2 g/d). The Montgomery-Asberg Depression Rating Scale (MADRS) was the primary outcome measure. Hot flashes were monitored prospectively using daily diaries and the Hot Flash Related Daily Interference Scale. Blood samples for plasma pretreatment and posttreatment essential fatty acid assays were obtained. Because of the small sample size, data were analyzed using nonparametric techniques. RESULTS: Of 20 participants treated with omega-3 fatty acids, 19 (95%) completed the study. None discontinued because of adverse effects. The pretreatment and final mean MADRS scores were 24.2 and 10.7, respectively, reflecting a significant decrease in MADRS scores (P < 0.0001). The response rate was 70% (MADRS score decrease of ≥50%), and the remission rate was 45% (final MADRS score of ≤). Responders had significantly lower pretreatment docosahexaenoic acid levels than nonresponders did (P = 0.03). Hot flashes were present in 15 (75%) participants. Among those with hot flashes at baseline, the number of hot flashes per day improved significantly from baseline (P = 0.02) and Hot Flash Related Daily Interference Scale scores decreased significantly (P = 0.006). CONCLUSIONS: These data support further study of omega-3 fatty acids for major depressive disorder and hot flashes in women during the menopausal transition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Omega-3 fatty acids in health and disease and in growth and development.
Simopoulos, A. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.3.438 · Cited by 2,162 · cited 1×
“The typical American diet is composed of a relative excess amount of omega-6 fatty acids compared with omega-3 fatty acids.(12) Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are omega-3 fatty acids found in fish and marine sources.”
BackgroundEpidemiology of women and depression
Kessler, R. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00426-3 · Cited by 2,006 · cited 1×
“The lifetime prevalence of MDD in women is greater than 20%, and hot flashes affect up to 80% of women during the menopausal transition.(1,2) Prospective studies have demonstrated an increased risk of onset of MDD during the menopausal transition,(3,4) and persistent mood symptoms have been demonstrated to affect 15%…”
BackgroundOmega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., Keck, P. E., Marangell, L. B., Richardson, A. J., Lake, J., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1217 · Cited by 709 · cited 1×
“Several different putative mechanisms of action have been proposed for central nervous system effects of omega-3 fatty acids.(14,15,27) The fluctuating and intermittently lowered levels of estrogen may contribute to the increased prevalence of depression in perimenopause.”
BackgroundSelf-citationLin, P.-Y., & Su, K.-P. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0712 · Cited by 481
Methodologic lessons learned from hot flash studies.
Sloan, J. A., Loprinzi, C. L., Novotny, P. J., Barton, D. L., Lavasseur, B. I., & Windschitl, H. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.23.4280 · Cited by 462 · cited 5×
“The diary used was adapted from the 7-day North Central Cancer Treatment Group Diary, a self-report tool for VMS.23 The diary was adapted so that nocturnal and daytime hot flashes could be recorded both together and separately.”
MethodInfluentialThe Hot Flash Related Daily Interference Scale
Carpenter, J. S. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00353-0 · Cited by 292 · cited 1×
“The HFRDIS is a 10-item self-report questionnaire that measures the degree to which hot flashes interfere with daily activities and quality of life during the prior week.(24)”
Background
Cited by
Stark, K. D., Van Elswyk, M. E., Higgins, M. R., Weatherford, C. A., & Salem, N. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.05.001 · Cited by 519
Okereke, O. I., Vyas, C. M., Mischoulon, D., Chang, G., Cook, N. R., Weinberg, A., Bubes, V., Copeland, T., Friedenberg, G., Lee, I.-M., et al. (2021) · JAMA · doi:10.1001/jama.2021.21187 · Cited by 121
Belzung, C. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.342 · Cited by 106
“…(review); 4Nations et al, 2012; 5Santos et al, 2008; 6Barbee et al, 2011; 7Riesenberg et al, 2012; 8Freund-Levi et al, 2008; da Silva et al, 2008; Freeman et al, 2011; Lespérance et al, 2011; 9van de Rest et al, 2008; Bot et al, 2010; 10Varty et al, 2003; Wallace-Boone et al, 2008; 11van der…”
Metadata
- Authors
- Freeman, M. P., Hibbeln, J. R., Silver, M., Hirschberg, A. M., Wang, B., Yule, A. M., Petrillo, L. F., Pascuillo, E., Economou, N. I., Joffe, H., & Cohen, L. S.
- Venue
- Menopause
- Published
- 2011-03
- Volume
- 18
- Issue
- 3
- Pages
- 279-284
- ISSN
- 1072-3714 (ISSN-L)
- OpenAlex
- W2044569835
- Cited by
- 50
- References
- 6
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.